Hazardous Drugs in the Urology Workplace: Focus on Intravesical Medications.

Abstract

The Society of Urologic Nurses and Associates (SUNA) and the American Urological Association (AUA) collaborated to develop a standard operating procedure in 2015 for instillation of intravesical cytotoxic, immunotherapeutic, and/or therapeutic drugs for patients with urothelial carcinoma of the bladder and interstitial cystitis. This is a synthesis of the standard operating procedure in the context of hazardous drug administration, including indications for administration, guidelines, and principles of hazardous drugs in the clinical setting, peri-treatment concerns, and patient and staff education.